GlassScriptPhysician profile
Nathaniel S Gamsky
NPI 1164955043
$3,799.89
in general payments reported to CMS, 2019-2025
16 companies · $405 in 2025
The $405 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.46 · 2022: $388 · 2023: $1,611 · 2024: $1,307 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,663 · Travel and Lodging: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,662.89 |
| Travel and Lodging | $659.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $743.07 | 2024-2025 | Reactiv8 |
| Painteq LLC | $501.99 | 2022-2024 | Painteq |
| Spr Therapeutics, INC | $452.06 | 2023 | Sprint Pns System |
| Abbott Laboratories | $427.28 | 2023-2024 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $324.75 | 2024-2025 | Evoke |
| Nevro Corp. | $312.87 | 2023-2024 | Senza |
| Biotronik Nro, INC. | $261.67 | 2024-2025 | Prospera |
| Medtronic, INC. | $221.89 | 2022-2023 | Intellis Adaptivestim, Synchromedii |
| Nalu Medical, INC. | $124.09 | 2023 | Nalu Neurostimulation System |
| Relievant Medsystems, INC. | $82.07 | 2023 | Intracept |
| Averitas Pharma INC. | $80.91 | 2023 | Qutenza |
| Boston Scientific Corporation | $60.19 | 2025 | Wavewriter Alpha Prime 16, Accolade Sr |
| Globus Medical, INC. | $41.82 | 2025 | Senza |
| Foundation Fusion Solutions, LLC | $33.03 | 2023 | |
| Si-Bone, INC. | $24.85 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Gamsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.